PathReD 2019 Invited Speakers

Dr Amir Afrogheh Dr Amir Afrogheh

Dr Amir Afrogheh is a consultant Head and Neck Pathologist at the National Health Laboratory Service, and a lecturer/specialist at the University of the Western Cape (UWC), Cape Town, South Africa. He graduated with a Master of Dental Surgery (MChD) in Oral and Maxillofacial Pathology and a PhD from the University of the Western Cape. Amir is the first oral pathologist to graduate from Harvard Medical School, Massachusetts General Hospital in June 2015 with a fellowship in Head and Neck Pathology. He is also the first to graduate from University of Stellenbosch (US), Cape Town, with a master's degree in the subspecialty of cytopathology. He is an international fellow of the College of American Pathologists, and a member of the Endocrine Pathology Society. He has been a regular invited speaker at major national and international pathology meetings. Thyroid/oral cytopathology, HPV-induced cancers of the head and neck, molecular pathogenesis of adenoid cystic carcinoma are his main areas of research interest. In recognition of his work, he has received numerous awards and prizes, including International Academy of Pathology ROC Kaschula award, and the US best research award.

Prof Lucille Blumberg Prof Lucille Blumberg

Prof Lucille Blumberg is a Deputy Director of the National Institute for Communicable Diseases, of the National Health Laboratory Service, and founding head of the Division of Public Health Surveillance and Response. She is currently medical consultant to the Division for Outbreak Preparedness and Response and also medical consultant to the Centre for Emerging, Zoonotic and Parasitic Diseases where her major focus is on malaria, rabies and zoonotic diseases. She has worked on a number of outbreaks of zoonotic diseases including rabies, avian influenza, leptospirosis and the Lujo virus. She is a medical graduate of the University of the Witwatersrand and is an Associate Professor in the Department of Medical Microbiology at the University of Stellenbosch, Western Cape. She has specialist qualifications in clinical microbiology, travel medicine, and infectious diseases. She lectures on ‘One Health’ to under- and postgraduate students at the Faculty of Veterinary Sciences, University of Pretoria and teaches on a number of international ‘One Health courses’. She is a member of the South African Expert Advisory Groups on Rabies and Malaria (Chairperson) as well as the advisory groups to the WHO on yellow fever risks in travellers (Chairperson), and the ‘Blue Print’ for research in diagnostics, vaccines and therapeutics for epidemic–prone (mainly zoonotic) diseases. She has been recognized for her work in One Health with an award from the World Small Animal Veterinary Association (WSAVA).

Dr Tendesayi Chakezha Dr Tendesayi Chakezha

Dr Tendesayi Chakezha is a Senior Epidemiologist at the National Institute of Communicable Diseases’ Centre for HIV and STIs. In this role she designs and implements relevant surveillance and operational research activities as well as mentor staff and students. A medical doctor by training, she holds a Master’s in Public Health (major in Epidemiology) and a PhD in Epidemiology. Over the past 18 years, she has held different positions in HIV, TB and STI prevention, care and treatment programmes and implementation science research. Her main areas of interest are the epidemiology and prevention of HIV, STIs and HIV -associated TB and the interaction of these diseases. Her current activities are case-based surveillance of congenital syphilis, evaluation of point-of-care technologies and HIV and STI integration at primary care levels.

Prof Zivanai Chapanduka Prof Zivanai Chapanduka

Prof Zivanai Cuthbert Chapanduka, DMLT(Gen), DMLT (Haem and Blood Transfusion), MBChB(Zim), FCPath(SA). Haem, MBA(Liverpool) is a Haematopathologist with Medical Laboratory Technology, Medical and Business qualifications. He is currently the Head of Haematological Pathology at NHLS Tygerberg Hospital and Stellenbosch University, Cape Town. After completing his internship at King Edward Hospital in 1991, Dr Zi trained in Haematology at the University of Natal Medical School teaching hospitals. He was the first ethnic African to be awarded the Fellowship of the College of Pathologist of South Africa – FCPath(SA) in Haematology (1995). Dr Zi has held senior management positions in various organisations including the Natal Blood Transfusion Service, Kwa-Zulu Clinical Laboratory, Drs Rambau, Seopela and Partners, Dr Bouwer and Partners Inc. (AMPATH), Armed Forces Hospitals in Saudi Arabia and in Eli Lilly and Company. He founded Busch Apothecary Pty Ltd in 2012. He has practised both Clinical and Laboratory Haematology in different institutions, locally and abroad and is actively involved in research in several aspects of Haematology and the business, administrative, leadership and management aspects of Pathology services.

Prof Marius Coetzee Prof Marius Coetzee

Prof Marius Coetzee grew up in Pretoria, did his internship at Baragwanath, and worked as a junior doctor in various places, including a stint in the Karoo. But his calling was pathology, specifically haematology. He obtained his FFPath(SA) in 1987. He interests include haemostasis and genetics. He has been the head of Haematology at the University of the Free State since 2010. His dream is to see haematology continue to blossom as a fascinating science, where young people can have fulfilling careers by serving those with blood diseases.



Ms Patience Dabula Ms Patience Dabula/span>

Ms Patience Dabula is a National QA Manager of the NHLS. She has a Master’s in Biomedical Technology with 18 years’ experience in implementing Total Quality Management for different ISO standards in public health and clinical trial laboratories, Proficiency Testing Schemes (PTS) and Support Service department. She is a SLMTA Hero and “Patron of SLMTA” who lead the implementation of SLMTA in South Africa. Under her leadership, the NHLS accredited over 40 laboratories. She is SANAS Lead Assessor and a member of three ISO committees of the SABS. Patience Heads the SADC Regional Center of Excellence (RCE) for Quality, is in charge of Health Technology Assessment Unit (HTA) and the PTS providing over 30 schemes to more than 25 Countries. She serves as a member of the Quality Control for Molecular Diagnostics (QCMD) PTS International Advisory Board. She served in the WHO’s Technical Working Group that developed the guidelines on Post-Market Surveillance (PMS) of IVDs and also lead the QA subcommittee that developed the South African Point of Care (POCT) Policy. Her work experience includes part time Lecturer in a UoT, Analytical Project Manager and Training and QA Officer supporting laboratories in several African Countries and India.

Dr Louis De Jager Dr Louis De Jager

Dr Louis De Jager, is a pathologist working in the Division of Anatomical Pathology at Tygerberg Laboratory. He has been working at the NHLS since 2011 when he started training as a registrar. He enjoys all aspects of surgical pathology, but has a particular interest in breast and placental pathology. He is involved in postgraduate teaching and various research projects.





Prof Tulio de Oliveira Dr Louis De Jager

Prof. Tulio de Oliveira, is a bioinformatician that has moved to South Africa in 1997. He has received his BSc at the Federal University of Rio Grande do Sul (UFRGS), Brazil and MSc/PhD at the Nelson R Mandela School of Medicine, UKZN, South Africa. He has been awarded two prestigious fellowships, a European Commission Marie Curie Fellowship at the University of Oxford, U.K. and a U.K. Royal Society Newton Advanced Fellowship at the Wellcome Trust Sanger Institute. He is the founder member and director of KRISP, which is a state-of-art genomics and bioinformatics centre at UKZN that delivers high level science, provides innovative omics services and reverses the brain drain. In the PathReD 2019 conference, he will highlight some of the high-throughput DNA sequencing and diagnostics services of KRISP and the use of bioinformatics analysis to elucidate viral and bacterial outbreaks in South Africa and abroad.

Bonginkosi Duma Mr Bonginkosi Duma

Bonginkosi Duma, is currently working as a Quality Assurance Manager NIOH for NHLS. The Biobank in NHLS currently has 1,2 million samples. He has also done International Quality Training in Egypt. He has both medical and pharmaceutical background for the past and been part of quality for the 19 years. He is also studying towards an MBA and has passed courses in Management and Organizational Behavior, Services Marketing, Statistics, Strategic Management and Marketing and the Environment. Currently doing Dissertation to finish end of 2018. He worked as a Group Quality Assurance Deputy Manager for Lancet in charge of 85 laboratories in South Africa and North Africa in Botswana, Zambia, Swaziland and Mozambique. He has extensive knowledge in Quality Assurance, Biobanking, Clinical Pathology, Project Management, ISO 17025, ISO 15189, GCLP, GLP. He is also a technical auditor for SANAS. He serves in ISBER Standards Committee international and a member of ISO committees.

Prof Adriano Duse Prof Adriano Duse

Adriano Duse, is the Professor and Head of Clinical Microbiology and Infectious Diseases in the School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. He began his career at the National Health Laboratory Services (the then SAIMR) as a medical technologist and went on to compete his MBBCh at Wits. He specialised as a Microbiologist and was appointed as a consultant before going onto becoming the Head of the Department in 2002. Prof Duse served as a Southern African Chair for the Global Antibiotic Resistance Partnership (GARP). GARP is a project of the Centre for Diseases Dynamics, Economics & Policy (CDDEP) which works to create greater awareness among policymakers in low-middle income countries about the growing threat of antibiotic resistance and to develop country-relevant issues. Professor Duse expertise in viral haemorrhagic fevers (VHFs) started in 1996 and resulted in him being appointed by the World Health Organisation, Geneva, to act as expert consultant and provide education to health care staff and case management during the 2005 Angolan Marburg viral haemorrhagic fever outbreak and the 2006/7 Kenyan Rift Valley fever outbreak.

Prof Rajiv Erasmus Prof Rajiv Erasmus MBBS

Prof Rajiv Erasmus, FMC.Path(Nig), FWACP, DABCC (Am Board Certified), DHSM(Natal), FCPath(SA), FCPath (ECSA). Prof Erasmus obtained his education in India, Malaysia, Ghana and medical and specialist degrees from Nigeria. He moved to Papua New Guinea in 1988 and to South Africa in 1995 as Professor and head of Chemical Pathology, University of Transkei, Mthatha. He joined Stellenbosch University in 2002 as HOD where he is currently an Emeritus Professor. He has published 200 articles and been a research fellow at the University of Virginia, USA and Karolinska Institute, Sweden. In 2008 he set up the first integrated laboratory management training program in Africa. He serves on several committees of the International Federation of Clinical Chemistry (IFCC) and is its current Public Relations Chair as well as the president of the Africa Federation of Clinical Chemistry (AFCC). He is a NRF rated scientist. Prof Erasmus is the vice president of the College of Pathologists of East, Central and Southern Africa (COPECSA) and the secretary of the South African Federation of Societies of Pathology (FSASP). He is a director at Quality First Academy, the only company providing integrated laboratory management training in Africa.

Prof Bernard Fourie Prof Bernard Fourie

Bernard Fourie, is Research Professor (Extraordinary) in the Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria. He is also associated as a Principal Investigator with the MRC Clinical Research Unit for Tuberculosis Biomarker-Targeted Intervention (UCT), an Associated Scientist of the MRC Research Unit for Antimicrobial Resistance (UCT), and International Council Member of the Autophagy, Inflammation and Metabolism Centre (NIH supported Centre of Excellence, University of New Mexico, Albuquerque, USA). Formerly, Bernard served as the Director of the National TB Research Programme of the MRC. His experience is in drug and vaccine development for TB, and in the refinement of molecular diagnostics procedures for drug resistant tuberculosis. Current research contributions are mainly in rapid molecular diagnostics for TB, studies of biomarkers for predicting risk of relapse in TB, and in developing inhaled BCG and clofazimine as new dosage forms for application in tuberculosis prevention and treatment.

Dr Siphokazi Gwiliza Dr Siphokazi Gwiliza

Bernard Fourie, is a pathologist based at the Division of Chemical Pathology, Dr George Mukhari Laboratory National Health Laboratory Services at Sefako Makgatho Health Sciences University. She obtained her MBChB from University of Pretoria in 2007. She completed her Medical Internship training at the Port Elizabeth Hospital Complex and Community Service at the East London Hospital Complex. She completed her postgraduate training at the Division of Chemical Pathology at University of Pretoria and her MMed mini-dissertation was titled: “Validity of calcium correction formulae: comparison of albumin-adjusted calcium and ionised calcium in a tertiary hospital”. She was admitted to the CMSA College of Pathologists in May 2017. Her current areas of interest include laboratory management, renal and metabolic diseases. She has a passion for teaching and is involved both at an undergraduate and postgraduate level.

Ms Tsakani Furumele Ms Tsakani Furumele

Ms Furumele, is currently employed by the National Department of Health as Director for Communicable Disease Control. Her professional career started in the hospital laboratory as a Medical Laboratory Scientist. She then joined the Limpopo Department of Health Malaria Control Programme and later transferred to the National Department of Health in 2004 to work in the Malaria Control Programme. In 2007 she was appointed manager of the national Emerging and Re-emerging Infectious Diseases Programme. She has been appointed in her current post since 2009. She holds a B.Sc (Medical Laboratory Science) and an M.Sc (Zoology – Medical Entomology) from the University of Limpopo. She also has attained a Masters in Public Health (MPH) from the University of Pretoria specializing in Epidemiology and Biostatisics.

Prof Jaya George Prof Jaya George

Prof Jaya George, BMBCH - University of Jos – Nigeria, DTM & H – University of Liverpool, MSc (Immunology) – University of Birmingham, PhD- University of Witwatersrand, FCPath (Clinical Pathology) College of Medicine of S Africa. Currently the Chair of the Department of Chemical Pathology, National Health Laboratory Service (NHLS) at the University of Witwatersrand. Area of expertise is in research on non-communicable diseases (NCDs) and the interaction of infectious diseases with NCDs. My initial work was on HIV and metabolic abnormalities, followed by vitamin D and the metabolic syndrome. More recently begun to work on tuberculosis and diabetes, and I am involved in a multi-site study in chronic kidney disease in South Africa which is impacted by HIV, diabetes, hypertension amongst others. Have published over 20 peer reviewed articles. Funders include the NHLS, University of the Witwatersrand, MRC of SA, GSK and Newton Fund as well as the Wellcome Trust

Dr Verena Gounden Dr Verena Gounden

Dr Verena Gounden, is the Head of Department for Chemical Pathology University of KwaZulu-Natal, Inkosi Albert Luthuli Central Hospital, NHLS. She completed her medical degree (MBChB summa cum laude) at the Nelson Mandela Medical School, University of Natal, after completion of internship and community service she was admitted to the chemical pathology registrar program at the University of Witwatersrand. Dr Gounden completed her FCP Part 2 and was appointed as a consultant chemical pathologist at Charlotte Maxeke Johannesburg Academic Hospital laboratory in 2010. She was awarded her MMed in 2010 for research examining the pharmacogenomics of the anti-retrovial Efavirenz followed by being appointed as a pathologist at IALCH chemical pathology laboratory in Durban. Dr Gounden was accepted 2012 in a 2 year NIH clinical research fellowship in the Department of Laboratory Medicine at NIH, Bethesda, USA. She gained significant experience working in a clinical mass spectrometry laboratory and setting up of HPLC and LC-MS/MS assays under the mentorship of Dr Steven Soldin. In 2016 Dr Gounden was appointed as head of the chemical pathology department at UKZN, IALCH. Dr Gounden was awarded 2017 the Loreal Unesco for Women in Science fellowship for her PhD study involving Bisphenol A levels in maternal child pairs, and also being an author of over 30 peer reviewed publications and book chapters.

Prof Nelesh Govender Prof Nelesh Govender

Prof Govender, began his career in public health in 2006 when he joined the NICD as Head of GERMS surveillance. He now heads CHARM. In this position, he works closely with the Department of Health to generate evidence to guide government policy. His particular area of expertise is in medical mycology and in the field of antimicrobial resistance (AMR) wherein his work has focused largely on the neglected area of antifungal resistance. He is a member of the Ministerial Advisory Committee on AMR and President of the Federation of Infectious Disease Societies of Southern Africa (FIDSSA). He is currently Principal Investigator on two large projects, funded by the US National Institutes of Health and the US CDC). He is an Associate Professor in the Department of Clinical Microbiology and Infectious Diseases at the University of the Witwatersrand and Honorary Associate Professor in the Division of Medical Microbiology at the University of Cape Town.

Prof Wayne Grayson Prof Wayne Grayson

Wayne Grayson, is an Honorary Professor in the School of Pathology at WITS University. Wayne obtained his MBChB degree from the U.F.S. and received his specialist training in Anatomical Pathology at WITS University and the S.A.I.M.R. He completed his PhD in 2001 and was a Principal Pathologist in the Division of Anatomical Pathology at WITS University and the N.H.L.S. until 2008, when he joined AMPATH National Laboratories. Main areas of interest include infectious diseases of the skin and HIV/AIDS-related pathology. Wayne is an Executive Committee member of the International Society of Dermatopathology and serves on the Editorial Board of the American Journal of Dermatopathology. He is a co-author of the chapters on infectious diseases of the skin and HIV-associated cutaneous pathology in McKee’s Pathology of the Skin, a co-author of Kaposi Sarcoma: A Model of Oncogenesis, and a contributing author of the recent W.H.O. publication on Tumours of the Skin. .

Dr Ahmad Haeri Mazanderani Dr Ahmad Haeri Mazanderani

Dr Ahmad Haeri Mazanderani is a clinical virologist based at the Centre for HIV & STIs at the National Institute for Communicable Diseases, Johannesburg. His primary responsibilities are HIV infant surveillance and linkage to care. He recently completed a PhD within the Department of Medical Virology at the University of Pretoria investigating the effect of antiretroviral prophylaxis on the quality of early infant diagnosis.




Prof Diana Hardie Prof Diana Hardie

Prof Diana Hardie, is a principal pathologist and head of the diagnostic virology laboratory at Groote Schuur Hospital. Her research interests centre around clinical virology, viral immuno-pathogenesis and infections in the immunocompromised host. Most of her 42 publications arise from studies set up to solve diagnostic challenges. As a teacher and college examiner, she has been involved in registrar training for many years. She is currently head of the Virology Expert Committee.




Dr Heather Hong Dr Heather Hong

Dr Heather Hong (PhD), is a medical scientist in the Centre for Vaccines and Immunology at the National Institute of Communicable Diseases (NICD). She is also a member of NICD Research Committee and the NICD Website Committee. In addition, she holds a joint appointment as lecturer/researcher within the Department of Virology at the University of Witwatersrand. Her responsibilities include molecular testing for measles and enterovirus, as well as epidemiological case investigations for the diagnosis of acute measles infection. Data is shared bimonthly with the National Department of Health, WHO and the NICD Multisectoral National Outbreak Response Team to track the status of measles-infection in the country, ensuring effective and efficient responses to all measles-confirmed cases. In addition, her current research focus is evaluating the role of indoleamine-2,3-dioxygenase as a biomarker for TB disease and/or TB therapy in serum, plasma or urine samples using a high throughput enzyme linked immunosorbent assay.

Dr Gillian Hunt Dr Gillian Hunt

Dr Hunt, is a senior scientist in the Center for HIV and STI at the National Institute for Communicable Diseases. The HIV Drug Resistance Surveillance Laboratory team consists of 6 staff and students involved in HIV drug resistance surveillance and research. The laboratory is designated by the World Health Organization as Regional Drug Resistance Testing Laboratory and performs surveillance testing for South African and neighboring countries. In addition, the team is involved in a number of clinical research projects and assay development activities



Dr Charlotte Ingram Dr Charlotte Ingram

Dr Charlotte Ingram, is currently the Medical Director and CEO for the South African Bone Marrow Registry (SABMR) based at Groote Schuur Hospital, Cape Town. Prior to this she was the medical director for the South African National Blood Transfusion Service (SANBS). Dr Ingram was the CEO for the clinical trial laboratory division of the Wits Health Consortium, a division of the University of Witwatersrand & previously headed up a molecular diagnostics unit for a reputable commercial business initiative for the sub Saharan African region. Her qualifications include both laboratory and clinical haematology - MMed (Haem) Wits and haematopathology - FCPathHaem (Wits) and a registered HPCSA Haematology clinical sub speciality. She also has a MBA (Wits). Dr Ingram was actively involved in HIV research & management of HIV disease & anaemia in the antenatal units of the Johannesburg hospital complex for many years. Dr Ingram was the country principal investigator (PI) for the REDS III study for South Africa until she left the organization in 2016 and was also the principal investigator for the SANBS CDC /PEPFAR Blood Safety & strengthening health systems program in South Africa. Dr Ingram has both administrative & previous board experience in relevant blood transfusion services and stem cell / bone marrow transplantation. She is also a member of the SANBS HREC (Human Research and Ethics) Committee and serves on the boards of the WCBS (Western Cape Blood Service) and SATiBA (The South African Tissue Banking Association).

Dr Farzana Ismail Dr Charlotte Ingram

Dr Farzana Ismail, is a Clinical Microbiologist and worked initially as consultant at a tertiary level Microbiology laboratory attached to the Steve Biko Academic Hospital providing specialist services in both infectious diseases and infection control. She is a senior lecturer at the University of Pretoria involved in training medical undergraduate and postgraduate students, including registrars in clinical microbiology and infection control. In 2017, she was appointed as the pathologist at the Centre for tuberculosis and now leads the WHO Supranational TB Reference laboratory section of the Centre providing support to other National TB reference laboratories in the region as well as conducting an external quality assurance program for high burden TB reference laboratories in Africa. She has a keen interest in drug resistant TB, diagnostic technologies, and patient centred care for TB. An important initiative has been reference laboratory support to clinicians managing difficult to treat and highly resistant TB patients in SA

Prof Nazir Ismail Prof Nazir Ismail

Professor Nazir Ismail was appointed in 2012 as the Head of the Centre for Tuberculosis incorporating the WHO supranational TB Reference Laboratory at the National Institute of Communicable Diseases/NHLS. He is a pathologist by training and is the lead tuberculosis researcher at NICD with a focus on TB diagnostics, epidemiology, public health responses and transmission. Two major national studies were completed under his leadership, the SA National TB Drug Resistance survey 2012-14 and the trends in microbiologically confirmed TB nationally and sub-nationally. In addition, he has directed development and significant outputs in the field of genomics using next generation technologies. Lastly, transmission studies of DR-TB across SA are being conducted providing new knowledge in understanding drivers of TB in a high burden setting.

Dr Sabelle Jallow Dr Sabelle Jallow

Dr Sabelle Jallow is a senior medical scientist at the Centre for Vaccines and Immunology at the National Institute of Communicable Diseases. I have over 20 years of experience in research of infectious diseases with particular focus on HIV, RSV and vaccine preventable diseases such as polio and measles. I have a BSc degree in Chemistry with minors in Biology and Mathematics from Mt. St. Vincent University (Canada; distinction-1996); an MSc in Molecular Biology from the Free University of Brussels (Belgium; great distinction-2004); and a PhD in Molecular Virology from the University of Antwerp (Belgium-2008). My early research focused on HIV-2 treatment and drug resistance. I later developed my immunological skills at the Nuffield Department of Medicine in Oxford University. I have since then been working in public health research of vaccine presentable diseases, with focus on the impact of HIV exposure on vaccine responses in children.

Prof Amanda Krause Prof Amanda Krause

Prof Amanda Krause, is a Medical Geneticist and currently Head of the Division of Human Genetics, NHLS, and School of Pathology, University of the Witwatersrand. Her major roles are to assess and counsel patients in Genetic Clinics, to supervise the genetics molecular diagnostic service, to teach and train medical genetics to both undergraduate and postgraduate students, and to conduct research aimed at understanding the molecular basis of genetic disease in South Africa. Current research is focussed around but no limited to investigating the complex molecular basis for Spinal muscular atrophy (SMA) in black South Africans. Professor Krause has published over 75 original articles in scientific journals, 3 book chapters, and has presented at more than 150 national and international conferences. She is currently President of the College of Medical Genetics in South Africa and Chair of the Genetic Expert Committee at the NHLS.

Dr Jonathan Louw Dr Jonathan Louw

Dr Jonathan Louw, MB.ChB, MBA, CEO of the South African National Blood Service (SANBS), which caters to the value chain of blood donation, testing and logistics through transfusion to patients across South Africa. Previously Co-CEO for the Global Healthcare Fund in Dubai, raising and deploying $1bn in Hospitals and Diagnostics in global growth markets. Prior he was the CEO and Managing Director at Adcock Ingram Holdings Limited. Dr Louw led the IPO of Adcock Ingram when it separated from the JSE-Listed TigerBrands and during his tenure the business adopted an aggressive growth strategy, re-investing manufacturing and R&D to achieve FDA and PIC/s accreditation in both. He then joined TigerBrands as the New Business Development Director. Dr Louw first joined the pharmaceutical industry through AstraZeneca. He practised as an Anesthetist at St. Mary's Hospital in London, having trained as an undergraduate at the University of Cape Town faculty of Medicine. He has also served as the President of the Pharmaceutical Industry Association of South Africa, representing the interest of local and multi-national pharmaceutical companies, and is a Board member of Generation Ubuntu (NYC) looking after Orphans afflicted with HIV/AIDS in South Africa.

Mr Felix Made Mr Felix Made

Mr Felix Made, received his MSc in Epidemiology and Biostatistics from the University of the Witwatersrand, and is a currently a Biostatistician for the National Institute for Occupational Health (NIOH), Gauteng Region. Prior to joining the NIOH, Felix worked as a Biostatistician for the Sydney Brenner Institute for Molecular Bioscience (SBIMB) under the Human Heredity and Health in Africa (H3Africa) involving cardiovascular diseases projects in 15 African countries in collaboration with the University of the Witwatersrand. While working for the SBIMB, he also got involved with Africa Wits-INDEPTH partnership for genomic research projects (AWI-Gen). Felix is currently a PhD in Biostatistics (with emphasis in exposure science) in the University of the Witwatersrand. His PhD research is centred around the use of Bayesian Hierarchical models in categorisation of coal dust exposure according to occupational exposure limits in South Africa. Felix has published several papers and presented both locally and internationally with notably presentation in 2018 receiving an African Academy of Science best research presentation and conceptual award

Ms Jeanneth Manganyi Ms Jeanneth Manganyi

Jeanneth Manganyi is a Registered Occupational Hygienist and Head of Occupational Hygiene Section at the National Institute for Occupational Health (NIOH). Her qualifications include a B-Tech Degree in Environmental Health from the University of Johannesburg and the Master of Public Health (Occupational Hygiene) from the University of the Witwatersrand. She is a PhD candidate at the University of the Witwatersrand. Prior to joining the NIOH in 2009, Jeanneth worked at Ergosaf Approved Inspection Authority for 7 years and was involved in health risk assessment, exposure monitoring and advisory support on control measures in a wide range of industries (including iron and steel, railway, power utilities, manufacturing and office building). In addition to her previous responsibilities she is involved in teaching & training and research into respirator fit testing and facial anthropometry for respirator design. Her current innovative research aims to improve the protection of workers using disposable respirators.

Dr Shelley Macaulay Dr Shelley Macaulay

Dr Shelley Macaulay is the Genetic Counselling Manager and a lecturer in the Division of Human Genetics at the National Health Laboratory Service and the University of the Witwatersrand (Wits), Johannesburg. She holds a Master’s degree in Genetic Counselling and a PhD in Clinical Epidemiology, both obtained from Wits. With over 10 years of experience in the genetic counselling profession, Dr Macaulay oversees the provision of genetic counselling services to patients in the academic hospitals around Johannesburg, and she coordinates the Master’s degree programme in Genetic Counselling at Wits. As a registered genetic counsellor, Dr Macaulay also consults with patients and families who have, or are at risk of, genetic conditions.

Sr Jo McAnerney Sr Jo McAnerney

Sr Jo McAnerney is a registered nurse with a diploma in statistics, from UNISA and research methodology from Rand Afrikaans University. She is employed as a nurse epidemiologist for the Centre for Respiratory Disease and Meningitis at the National Institute for Communicable Diseases (NICD). She was instrumental in starting the Viral Watch influenza sentinel surveillance programme in 1984, and has published a number of peer reviewed articles in the field of influenza.




Dr Lazarus Kuonza Dr Lazarus Kuonza

Dr Lazarus Kuonza is the Head of South Africa’s Notifiable Medical Conditions Surveillance System (NMCSS), which is within the Division of Public Health Surveillance and Response of the National Institute for Communicable Diseases (NICD). He is a medical epidemiologist with over 17 years’ experience in clinical medicine, public health practice, and research. Dr Kuonza also serves as an honorary senior lecturer of epidemiology at the School of Public Health of the University of Witwatersrand, and the School of Health Systems and Public Health of the University of Pretoria.


Mr Thinyane Molelle Mr Thinyane Molelle

Mr Thinyane Molelle the Head: NHLS Learning Academy since 2014. Is a Senior Professional in Corporate Education (SPCU) and Corporate University Model. Is a founding Chief Learning Officer (CLO) of academies in various industries and companies like Finance (SARS), mining (Lonmin), Automotive (Toyota South Africa), Health (NHLS) and Free State Learning Institute (government). He was a Chief Director: Human Resource for the North West and Free State Governments; as well as the Chief Operations Officer (COO) of the ETP SETA. The highlights of his career include the appointment by President Mandela as the Commissioner for Special Needs in Education and Training (Government Gazette, No. 16874, Vol. 366 of 8 December 1995)

He is a senior graduate in MA: Human Resource Development (HRD) obtained in 1992 at Hampton University in the United States. He is currently a PhD candidate at University of Free State in STEM Education focusing on the application of artificial intelligence in massive open online platforms. He is a Lean Six Sigma Black Belt and signatory of the Cape Town Open Education Declaration and proponent of Free Higher Education in terms of the Paris Declaration on Open Educational Resources, Universal Declaration of Human Rights (International Covenant on Economic, Social and Cultural Rights, Article 13.1), Budapest Open Access Initiative and so forth.

Prof Lynne Morris Prof Lynne Morris

Prof Lynn Morris is the Interim Executive Director of the National Institute for Communicable Diseases (NICD) and Principal Medical Scientist in the HIV Virology Section, Centre for HIV & STI’s at the NICD, Johannesburg, South Africa. She holds a joint appointment as Research Professor at the University of the Witwatersrand and is an Honorary Senior Scientist at CAPRISA. She completed her undergraduate studies at Wits University and obtained a DPhil from the University of Oxford in 1988. Lynn is an NRF A-rated researcher (leading international scholar) who has made significant contributions to our understanding of how the antibody response to HIV develops and is responsible for conducting validated end-point assays for HIV vaccine clinical trials. She has been recognised through several national and international awards including The World Academy of Sciences (TWAS) 2018 Prize in Medical Sciences. She has supervised 30 PhD and MSc students, has published over 250 papers holding a current author H-Index of 58 and features on the Clarivate list of highest cited researchers in the world.

Dr Pulane Mosiane Dr Pulane Mosiane

Dr Pulane Mosiane obtained her MBChB degree from the University of Natal in 2001. Following internship and community service, she undertook her specialist training in Anatomical Pathology at the University of the Witwatersrand where she qualified with an FcPath (Anat) in 2008. She has a keen interest in renal pathology and is in charge of the renal pathology division in the Charlotte Maxeke Johannesburg Academic Hospital Histopathology laboratory. She was a recipient of the ISN mini sabbatical in 2014 which afforded her the opportunity to spend time at Vandebilt University in Nashville, TN with Professor Agnes Fogo. Dr Mosiane is currently involved in several research projects within her department both as a supervisor for Bsc Honours and MMed students. Her interests are “HIV infection and the kidney” and Lupus nephritis. She has presented several posters at local and international academic meetings.

Osmond Muroyiwa Osmond Muroyiwa

Osmond Muroyiwa has extensive experience in sales, marketing, strategy development and implementation across the medical, financial services, management consulting& IT industries in Zimbabwe, South Africa & Ghana. Currently engaged as a Portfolio Manager - Health Innovation at the Technology Innovation Agency (TIA), Osmond is part of a team responsible for conducting pre-investment activities such as commercial and technical due diligence culminating in structuring of investment deals, as well as handholding &developing go-to-market strategies for innovative South African entrepreneurs and innovators in the health sector post-investment He has published in the prestigious South African Journal of Business Management& is also a member of the Institute of Business Advisors of South Africa He is a past recipient of the Africa Academic Excellence Scholarship at the Wits Business School – South Africa’s leading business school MBA (Wits), BSc. Applied Biology & Biochemistry (NUST), Dipl. Marketing (London Chamber of Commerce

Dr Nkengafac Villyen Motaze Dr Nkengafac Villyen Motaze

Dr Nkengafac Villyen Motaze is (M. D, M.Sc, PhD fellow) is an epidemiologist with the Centre for Vaccines and Immunology, (CVI) at the National Institute for Communicable Diseases (NICD). Villyen completed his masters in Clinical Epidemiology at Stellenbosch University where he is now a PhD fellow in Epidemiology. He currently conducts systematic reviews of healthcare interventions and facilitates training on systematic reviews and Evidence-Based Practice in partnership with the Centre for Evidence-Based Health Care, Stellenbosch University and Cochrane South African, South African Medical Research Council. Villyen was a participant at the first ever Global Outbreak Alert and Response Network (GOARN) training that took place on the African continent. Following this training, he has been deployed twice as a World Health Organization consultant to support outbreak preparedness and response activities following ebola outbreaks in the Democratic Republic of Congo. Villyen’s areas of interest include infectious diseases, vaccine preventable diseases, child health and reproductive health.

Dr. Senzo Mtshali Dr. Senzo Mtshali

Dr. Senzo Mtshali is a Senior Medical Scientist at the National Institute for Communicable Diseases (NICD), and based at the NICD Sequencing Core Facility. He has a BSc in Biological Sciences and BSc (Hons) in Zoology from the University of Zululand. He obtained his MSc and PhD (Biotechnology) from Stellenbosch University. Senzo obtained postdoctoral training at the National Zoological Gardens of South Africa (NZG) where he worked on the molecular epidemiology of bovine parasites. Recently (November 2018), Senzo had a privilege to be invited to participate in a 11-day hands-on training program on the Molecular Diagnosis and Pathogen Determination Techniques for Emerging and Reemerging Infectious Diseases (China CDC ModPad Training Program) organised and hosted by China CDC in Beijing, Wuhan and Shenzen. In his career as a scientist, Senzo has published more than 10 peer-reviewed articles

Dr Portia Mutevedzi Dr Portia Mutevedzi

Dr Portia Mutevedzi holds a PhD in Epidemiology and Population Health; an MSc (Medicine): Epidemiology and Biostatistics. Prior to joining the Respiratory and Meningeal Pathogens Research Unit (RMPRU), she worked for the National Institute for Communicable Diseases (NICD) for five years, initially as the provincial epidemiologist for KwaZulu-Natal Department of Health; a position she held for one year before being promoted to Senior Public Health Epidemiologist for the NICD. During her NICD tenure, she led the re-engineering of the current national surveillance system for notifiable diseases and was instrumental in implementing the provincial epidemiologist support team to all Provincial Departments of Health across South Africa. She has over a decade of research and public health experience and has sat on national and international committees including the Global Health Security Agenda (GHSA) in South Africa and the WHO expert committee on development of public health emergency operations centers. Dr Mutevedzi is currently senior epidemiologist for RMPRU and is the principle investigator for the current national Expanded Programme on Immunization (EPI) coverage survey

Dr Nokwazi Nkosi Dr Nokwazi Nkosi

Dr Nokwazi Nkosi Nokwazi Nkosi is a Virologist at the Division of Medical Virology, Tygerberg NHLS Virology, Department of Pathology, Stellenbosch University. She is involved in academic, clinical, diagnostic and research activities within the Division of Medical Virology. She qualified at the University of Cape Town (FCPath SA (Viro), MMed) in 2017. Undergraduate training was attained at the University of KwaZulu-Natal in 2005.




Dr Sharol Ngwenya Dr Sharol Ngwenya

Doctor Ngwenya attended the University of the Witwatersrand in Johannesburg and graduated with her MBBCh in 2003. She worked as an intern at Helen Joseph Hospital. After working as a medical office for three years at Pholosong Hospital in Johannesburg she elected to specialise in Anatomical Pathology and obtained her specialised qualification (FCPath (Anat) SA) in 2013. Since specialising she has devoted her time to practice at Charlotte Maxeke Johannesburg Academic Hospital and has a special interest in liver and gastrointestinal pathology. She was one of the pathologists responsible for the Liver Transplant Unit histopathology specimens from Donald Gordon Medical Centre (DGMC) from 2014 to 2019. She is a lecturer in the Faculty of Health Sciences, University of the Witwatersrand at undergraduate and postgraduate level.

Prof Jessica Opie Prof Jessica Opie

Prof Jessica Opie is a haematology pathologist who leads the diagnostic haematology service at the National Health Laboratory Service, Groote Schuur Hospital (GSH). She has 14 years’ experience as a haematology pathologist in the GSH tertiary academic laboratory including morphology, flow cytometry, haemoglobinopathy testing, coagulation, molecular haematology and cytogenetics. She is closely involved with teaching, training and examining postgraduate doctors (registrars) specialising in Haematology Pathology, Clinical Pathology and Clinical Haematology. Her particular interests include the haematological complications of HIV, HIV-associated lymphomas and post graduate teaching and training in haematology pathology. Jessica’s vision is to build clinically relevant research collaborations locally and internationally, whilst delivering a high quality haematology diagnostic service to contribute to the improved health of our population. Jessica is a member of the International Society of Laboratory Haematology, the Royal College of Pathologists of Australasia, and the South African Society of Haematology

Dr Nicola Page Dr Nicola Page

Dr Nicola Page is a principal scientist, leading the Virology Division of the Centre for Enteric Diseases at the National Institute for Communicable Diseases. She also holds an extra-ordinary professor position within the Department of Medical Virology at the University of Pretoria. She completed her undergraduate training at the University of Pretoria in 1995 (cum laude), following up with an Honours degree in 1997. She moved to the Medical University of South Africa, under the guidance of Prof Duncan Steele and competed an MSc(Med) in Medical Virology and a PhD. She also completed an MPH at the University of Pretoria, graduating cum laude. She is a member of several national and international professional associations and working groups. She has authored or co-authored more than 44 refereed articles in scientific journals, worked on the WHO Manual of rotavirus detection and characterization and was a guest editor on the Journal of Infectious Diseases – Rotavirus in Africa supplement. She is a principal investigator on projects supported by national and international funding agencies.

Prof Olga Perovic Prof Olga Perovic

Prof Olga Perovic MD, DTM&H, MMed (WITS), FC PATH (SA) MICRO is Lead- Antimicrobial Resistance Laboratory and Culture Collection at National Institute for Communicable Diseases and Associate Professor at Clinical Microbiology and Infectious Diseases of School of Pathology, University of Witwatersrand. Head WHO Collaborative Centre for AMR Honorary Research Fellow in the School of Health Science, University of Kwazulu-Natal, Westville Campus. She has broad laboratory based research experience in microbiology, with a focus on antimicrobial resistance in bacterial organisms and has led antimicrobial resistance surveillance program on AMR since 2010. Currently she is involved in a number of nested studies on AMR surveillance. She is a member of Strategic and Technical Advisory Group (STAG) on AMR and a member of Global Antimicrobial Resistance Surveillance System GLASS at World Health Organization (WHO). She is also a member of Ministerial Advisory Committee (MAC) on AMR at NDoH, member of Global Antibiotic Resistance Partnership (GARP) in South Africa and Chair of National Advisory Committee on Antimicrobial Susceptibility Testing (NAC).

Dr Tirelo Pitjadi Prof Tahir Pillay

Tahir Pillay is Chief Specialist, Professor and Head of the Department of Chemical Pathology, University of Pretoria and National Health Laboratory service, Steve Biko Academic Hospital, head of the Division of Clinical Pathology and Clinical Pathology training programme, Head of the UP Pathology Cluster and Honorary Professor of Chemical Pathology, University of Cape Town. He was also previously head of Chemical Pathology at the University of Cape Town and Deputy Vice Chancellor at the University of KwaZulu-Natal; Deputy Director, Institute of Cell Signalling, University of Nottingham, UK. He is President of the South African Association for Clinical Biochemistry and Laboratory Medicine. He has just been appointed by the Executive board of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), to head one of the 3 divisions (Communications and Publications DIvision) of the IFCC from January 2019 and is the first person from the African continent to head a division of the IFCC since its inception in 1952. He is currently the only full Professor of Chemical Pathology in South Africa and is also NRF-rated.

Dr Tirelo Pitjadi Dr Tirelo Pitjadi

Dr Tirelo Pitjadi is a Consultant Histopathologist at Ampath National Laboratories in Fourways, where he forms part of a team of Pathologists entrusted with delivering quality Dermatopathology services to regional Dermatologists, Plastic Surgeons and their patients. Tirelo obtained his MBBCh degree from the University of the Witwatersrand, Johannesburg in 2006. He developed a particular interest in cutaneous pathology during his subsequent postgraduate training in the Division of Anatomical Pathology at WITS University. He was admitted to the College of Pathologists of South Africa in 2015, and served as a lecturer and Consultant Pathologist in the School of Pathology at WITS University and the NHLS. until 2017, when he joined Ampath National Laboratories. Tirelo is an Honorary Lecturer in the School of Pathology at the University of the Witwatersrand, where he remains actively involved in the teaching of Dermatopathology to Registrars in the Divisions of Anatomical Pathology and Dermatology.

Dr Jaishree Raman Dr Jaishree Raman

Upon the completion of her post-doctoral fellowship in Sweden, Dr Raman joined the Malaria Research Unit of the South African Medical Research Council. During her 10 year tenure there she established and led a successful research programme focusing on understanding the emergence and spread of antimalarial drug resistance across southern Africa. Data generated by the laboratory informed antimalarial drug policy in South Africa, Eswatini and Mozambique. In 2014, Dr Raman’s research programme moved to the National Institute for Communicable Diseases, where in line with national policy, research activities within her laboratory are directed to towards assisting South Africa achieve its malaria elimination goal. In addition to running a robust antimalarial resistance surveillance programme, the laboratory, in collaboration with national and international partners, is investigating novel techniques and technologies aimed at improving malaria case detection and treatment practices within southern Africa, with the aim of accelerating the region towards malaria elimination.

Prof Michele Ramsay Prof Michele Ramsay

Michèle Ramsay (PhD) is the director of the Sydney Benner Institute for Molecular Bioscience at the University of the Witwatersrand, Johannesburg, Professor in Human Genetics and South African Research Chair holder in Genomics and Bioinformatics of African Populations. As a member of the Human Heredity and Health in Africa Consortium (H3Africa) she leads the AWI-Gen study on the genetic and environmental contributions to obesity and cardiometabolic disease risk in six centres across four African countries. Her research aims to shed light on the role of African population genomic variation in susceptibility to diseases, given the ethnolinguistic and environmental diversity across the continent. She is the President of the International Federation of Human Genetics Societies and the past President of the African Society of Human Genetics.

Prof David Rees Prof David Rees

Professor David Rees (MBBCH, DOH, MSc{Med}, PhD) is an occupational medicine specialist. He was the Director: National Centre for Occupational Health from 1998 to 2003. He is currently Head of the Division of Occupational Medicine and Epidemiology at the National Institute for Occupational Health, NHLS, and Professor of Occupational Health, School of Public Health, University of the Witwatersrand. Prof Rees has published about 100 peer-reviewed articles. Prof Rees obtained the following awards in his career: Joan and Ian Webster Gold Medal in Occupational Health (1986), W. Harding le Riche Gold Medal in Epidemiology (1990), Member of Faculty of Occupational Medicine (MFOM), Royal College of Physicians, UK (1997), Faculty of Health Sciences, University of the Witwatersrand, Award for Exceptional Service (2004), and Faculty of Health Sciences, University of the Witwatersrand, recognition for dedication and achievement in research (2015).

Dr Jan Roodt Dr Jan Roodt

Dr Jan Roodt has been a scientist in the department of Haematology and Cell Biology at the University of the Free State for 37 years. He specializes in the role of blood platelets in thrombosis and has 25 years’ experience in using and developing primate models of various thrombotic diseases. Recently they have developed models for arterial thrombosis and Thombotic Thrombocytopaenic Purpura (TTP) and have tested various experimental drugs successfully in these models. He is also currently involved in flow cytometry.



Dr Sabiu Saheed Dr Sabiu Saheed

Dr. Sabiu Saheed is a South African National Research Foundation (NRF) Y-rated researcher and a Senior Lecturer at the Department of Biotechnology and Food Technology, Durban University of Technology (DUT). In addition to his interests in Human Genetics, Phytopharmacology and Molecular Biotechnology, Dr. Sabiu is a faculty representative on HIV/AIDS committee at DUT and an Affiliate Researcher with the Next-Generation Sequencing (NGS) Unit of the University of the Free State (UFS), where the focus of his research is on enteric viruses using whole genome sequencing and metagenomic approaches. Dr. Sabiu has significant publications to his credit and reviewing for more than ten good impact factor journals. He is a multiple academic award winner, a registered Professional Natural Scientist with the South African Council for Natural Scientific Professions, and a member of several national and international scientific organizations.

Dr Juno Thomas Dr Juno Thomas

Dr Juno Thomas heads the Centre for Enteric Diseases at the National Institute for Communicable Diseases of the National Health Laboratory Service in Johannesburg, South Africa. Her areas of expertise include communicable disease epidemiology, surveillance and outbreak response. Juno and her team lead syndromic and laboratory-based surveillance activities for priority enteric bacterial and viral pathogens (including typhoid fever, salmonellosis, cholera, listeriosis, shigellosis and rotavirus). She also oversees the food- and water-borne disease outbreak investigation and response activities of the centre, providing key epidemiological and laboratory support to the South African National Department of Health as well as neighbouring southern African countries. Her research activities focus on identifying opportunities for locally relevant public health interventions for endemic enteric diseases and foodborne disease outbreaks.

Dr Dieter van der Westhuizen Dr Dieter van der Westhuizen

Dr Dieter van der Westhuizen is a Chemical Pathology registrar at the University of Cape Town, working at the NHLS Groote Schuur Hospital and Red Cross Children's War Memorial Hospital. He completed his M.B.Ch.B degree at the University of the Free State in 2014, completed internship at Universitas and Pelonomi Hospitals in 2016 and community service at 3 Military Hospital in Bloemfontein in 2017. He is inspired by innovation in the lab with regards to IT, lab automation, electronic devices and open source hardware. Current running projects: Development of a low-cost ELISA TSH screening test to be used for screening newborns for congenital hypothyroidism in the Western Cape; GFR measurement by iohexal clearance, measured by HPLC-TOF MS and its comparison to estimated GFR formulae in children and adults in the Western Cape; Prediction of kidney disease using big data.

Dr Abraham van Wyk Dr Abraham van Wyk

Dr Abraham van Wyk, MBChB, DA (SA), MMed (Anat Path), is a Senior Pathologist in the Division of Anatomical Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University and National Health Laboratory Service, Tygerberg Hospital, Cape Town, South Africa. He has a special interest in urological pathology. Current research interests include the role of human papillomavirus in penile cancer and prostate cancer in men of African descent. He is a member of the International Society of Urological Pathology (ISUP).



Dr Helena Vreede Dr Helena Vreede

I am a chemical pathologist in the National Health Laboratory Service (NHLS), appointed in the department of chemical pathology at the University of Cape Town and working in the routine diagnostic laboratory at Groote Schuur Hospital. I have an interest in laboratory information systems, data analysis and laboratory management. My role involves mainly service delivery, and optimising the quality of service we deliver to our clients particularly to the department of health. I have been involved in the setting up of the NHLS’ laboratory information system, electronic gatekeeping (a form of demand management), optimising various modes of results delivery, and improving test turnaround times with automatic authorisation of results. My work with information systems is not restricted to chemical pathology, but is often cross-discipline. I am currently the chair of the chemistry expert committee of the NHLS.

Dr Sibongile Walaza Dr Sibongile Walaza

Sibongile Walaza is a medical doctor with MSc in Epidemiology and biostatistics and a PhD in Public Health from the University of Witwatersrand. She is employed as a medical epidemiologist for the Centre for Respiratory Disease and Meningitis at the National Institute for Communicable Diseases in South Africa. Her responsibilities include implementation of the surveillance programmes, developing the protocols for the expanded surveillance for severe respiratory illness and the pneumonia surveillance and field implementation of these protocols. In addition, she is the principal investigator in the protocol for surveillance for hospital-acquired respiratory infections in South Africa. She has a joint appointment as a lecturer at the School of Public Health, University of the Witwatersand and has co-supervised Msc Students in the field of epidemiology. She has published a number of peer reviewed articles in the field of influenza and other respiratory illnesses. She has contributed to the development of guidelines for prevention and management of influenza in South Africa and is a member of the National influenza planning Committee.

Dr Tina-Marie Wessels Dr Tina-Marie Wessels

Dr Tina-Marie Wessels MSc(Med) Genetic Counselling, PhD obtained her Masters and PhD in Genetic Counselling at the University of the Witwatersrand (Wits). After qualifying, she worked as a genetic counsellor in the department of Human Genetics at Wits and the then SAIMR. She then briefly joined the National department of Health (1998 to 2000) but missed clinical work and returned to Wits. In 2001, she was appointed Manager Clinical Genetics in the Division Human Genetics at the National Health Laboratory Service (NHLS) and Wits. She moved to Cape Town and joined the Division of Human Genetics at the University of Cape Town (UCT) in 2014. She is currently a Senior Lecturer in Genetic Counselling and the course convener of the Genetic Counselling Programme at UCT. In addition to her academic role, she forms part of the clinic team that provides genetic counselling services to patients from Groote Schuur and Red Cross Children’s Hospital.

Dr Jacqueline Weyer Dr Jacqueline Weyer

Dr Jacqueline Weyer Jacqueline Weyer is a Principal Medical Scientist in the Center for Emerging and Zoonotic Diseases of the National Institute for Communicable Diseases since 2007. Here she is tasked with the laboratory investigation (diagnostics and research) of human rabies and viral heamorrhagic fevers and other emerging zoonotic disease of concern to the health of the South African public. She acts as the Lead Medical Scientist for the Special Viral Pathogens Laboratory and also serves as a member of the leadership team of the Center. Before taking up her task at the NICD, she completed her PhD in Microbiology at the University of Pretoria on the subject of recombinant poxvirus based vaccines for rabies at the age of 26. From 2004 to 2005 she was employed as Research Fellow with the Rabies Unit of the Centers for Disease Control and Prevention, Atlanta Georgia, United States of America. In 2006 she was awarded the L’Oreal-UNESCO, Department of Science and Technology Woman in Science Award: PhD Fellowship for Life Sciences. In 2018 she was awarded the degree Master of Public Health, cum laude from the Sefako Makgatho Health Sciences University in South Africa.


Institution Abbreviations: : CDC – Centre for Disease Control and Prevention, NDoH – National Department of Health, NHLS – National Health Laboratory Service, NICD – National Institute for communicable diseases, NRF– National Research Foundation, SAMRC – South African Medical Research Council, SU – Stellenbosch University, UL – University of Limpopo, USAID – United State Agency for International Development, NIH ACTG – National Institute of Health AIDS Clinical Trial Groups, WHO – World Health Organization, WITS – University of the Witwatersrand , DST- Department of Science & Technology, IOL - International Labour Organization, NIOH – National Institute for Occupational Health, SAAVI – South African AIDS Vaccine Initiative, UCT – University of Cape Town, USA – United State of America.


 

PathRed Evaluations

Click to Evaluate

Already Registered

Click to login

Abstracts Booklet

Download

View Invited Speakers

PathReD Scientific Programme

Workshop Programme


Important Dates

18 March 2019 Early Bird Registration: opens

07 April 2019 Early Bird Registration: closes

10 May 2019 Standard Registration: closes

05 June 2019 Late registration: closes